Barely Significant
← all phrases

“borderline significant”

11,410 sentences · 11,410 papers · 14,072 search hits before verification · confirmed specimen

Sighted at

p=0.09

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

borderline significantp = 0.05001.0× alphagold
1 , Panel B) [median: 2.220 (IQR: 0.908–3.647) vs 0.461 (IQR: 0.353–1.048); p = 0.0373], while between CC and CT groups a borderline significant difference was observed both at basal level ( Fig. 1 , Panel A) [median: 1.420 (IQR: 0.875–1.655) vs 0.676 (IQR: 0.468–1.137); p = 0.0500] and after exposure to IFN-alpha ( Fig. 1 , Panel B) [median values: 2.220 (IQR: 0.908–3.647) vs 0.840 (IQR: 0.397–1.599); p = 0.0500].
borderline significantP=0.051.0× alphagold
In the right colon, the ratio of the baseline value was significantly higher after PEG (P=0.01) and borderline significant after prucalopride (P=0.05) as compared to placebo for all the time points after the meal.
UEG Week 2014 Oral Presentations
United European Gastroenterol J · 2014 · PMC4212304
borderline significantP = 0.051.0× alphagold
ygen saturation in venules proximal from the branching (from 60.1% ± 2.0% to 64.5% ± 1.7%, P = 0.004) and in peripheral venular branches (from 66.9% ± 2.5% to 71.8% ± 1.9%, P = 0.003) but no significant increase in the macular venules (from 80.0% ± 1.8% to 82.5% ± 1.5%, although this difference was borderline significant [ P = 0.05]).
borderline significantP ≥ 0.051.0× alphagold
Our results showed a significant excess of nonsynonymous variants ( P = 0.047) in the Kinh population from Vietnam and a borderline significant excess of amino acid variation (0.1 ≥ P ≥ 0.05) in other populations of African (African Americans and the Mende), South Asian (Bengali, Gujarati, Telugu, Punjabi and Sri Lankan Tamil), European (Finnish, Great British, and Iberian), and East Asian (Dai and southern Han Chinese) ancestry (Table 1 ).
borderline significantp = 0.051.0× alphagold
In females, we also found a borderline significant association of higher plasma IGF1 levels with cardiovascular mortality (0.43, 0.18–1.00; p = 0.05; see Supplemental Table S2 , Model 1), but neither a significant association with cancer-related mortality (1.50, 0.45–4.93; p = 0.51; see Supplemental Table S3 , Model 1), nor with mortality from miscellaneous causes (0.43, 0.10–1.78; p = 0.24; see Supplemental Table S4 , Model 1).